Docetaxel EP Impurity A with CAS No:1887057-05-7 is an impurity standard of Docetaxel. Docetaxel is a chemotherapy medication belonging to the taxane class and is commonly used in the treatment of various cancers, including breast cancer, lung cancer, and prostate cancer. Its mechanism of action involves disrupting the microtubule structures in cancer cells, preventing their normal function and inhibiting cell division. By interfering with the cancer cell cycle, docetaxel helps to slow down or stop the growth and spread of cancer cells. This chemotherapy agent is typically administered intravenously and may be part of combination therapies for different types of cancer. While effective, docetaxel is associated with potential side effects, and its use is carefully managed by healthcare professionals based on the specific cancer type and the patients overall health condition. Buy high quality Docetaxel EP Impurity A from from Chemicea Pharmaceuticals. Chemicea Pharmaceuticals is one of the leading manufacturer and exporter of Docetaxel EP Impurity A
Chemical Name:
5β,20-epoxy-1,7β,10β-trihydroxy-9-oxotax-11-ene-2α,4,13α-triyl 4-acetate 13-[(2R,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-3-phenylpropanoate] 2-[(2E)-2-methylbut-2-enoate] (as per EP)
Request for Quotation : Docetaxel EP Impurity A
Search by Keywords - Buy 1887057-05-7 | Purchase 1887057-05-7 | Order 1887057-05-7 | Enquire 1887057-05-7 | Price of 1887057-05-7 | 1887057-05-7 Cost | 1887057-05-7 Supplier | 1887057-05-7 Distributor | 1887057-05-7 Manufacturer | 1887057-05-7 Exporter | Docetaxel EP Impurity A for Method Validation | Docetaxel EP Impurity A for ANDA Filing | Docetaxel EP Impurity A for Forced Degradation Studies | Docetaxel EP Impurity A Identification Standards | Docetaxel EP Impurity A for DMF Filing | Docetaxel
We have received your request successfully. Thank you for your interest in our product line. To
provide you with a Quotation, Our Sales team will contact you shortly.
Chemicea Pharmaceuticals Pvt. Ltd.
Thank You
You will receive blog content, featuring scientific research and exclusive promotions.